The Economist: All Audio

00:00

Oct 12, 2016 Our technology editor examines the long-term fallout after Samsung's flagship smartphone is pulled from production. The Food and Drug Administration's approval of a new drug for muscular dystrophy proves controversial and Matt Kaplan explains why higher-class people spend less time looking at their fellow humans For information regarding your data privacy, visit acast.com/privacy

You're listening to
The Economist: All Audio
on demand via

Personalized news and talk radio for your commute, workout and on-the-go.